TRCT
WGS icon

Tower Research Capital (TRC)’s GeneDx Holdings WGS Stock Holding History

Tower Research Capital (TRC)’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.6K Buy
1,053
+666
+172% +$60.7K ﹤0.01% 2493
2025
Q4 		$50.3K Sell
387
-2,867
-88% -$394K ﹤0.01% 2408
2025
Q3 		$351K Buy
3,254
+1,436
+79% +$156K 0.01% 1082
2025
Q2 		$168K Buy
1,818
+1,504
+479% +$118K ﹤0.01% 1948
2025
Q1 		$27.8K Buy
314
+111
+55% +$9.63K ﹤0.01% 2674
2024
Q4 		$15.6K Sell
203
-2,086
-91% -$146K ﹤0.01% 3394
2024
Q3 		$97.1K Buy
+2,289
New +$77.3K ﹤0.01% 2254
2024
Q1 		– Sell
-900
Closed -$2.48K – 6190
2023
Q4 		$2.48K Sell
900
-9,186
-91% -$21.4K ﹤0.01% 5212
2023
Q3 		$36.7K Buy
+10,086
New +$55.3K ﹤0.01% 2838
2023
Q2 		– Sell
-1,199
Closed -$14K – 6390
2023
Q1 		$14K Sell
1,199
-76
-6% -$1.01K ﹤0.01% 3923
2022
Q4 		$11K Buy
1,275
+905
+245% +$19.9K ﹤0.01% 3883
2022
Q3 		$11K Sell
370
-729
-66% -$33.4K ﹤0.01% 4476
2022
Q2 		$46K Buy
1,099
+1,097
+54,850% +$74.4K ﹤0.01% 2976
2022
Q1 		$0 Sell
2
-869
-100% -$96.6K ﹤0.01% 6586
2021
Q4 		$128K Buy
871
+867
+21,675% +$194K ﹤0.01% 2071
2021
Q3 		$1K Sell
4
-11
-73% -$3.78K ﹤0.01% 5546
2021
Q2 		$7K Buy
15
+11
+275% +$4.72K ﹤0.01% 4571
2021
Q1 		$2K Sell
4
-11
-73% -$5.72K ﹤0.01% 5056
2020
Q4 		$5K Buy
+15
New +$5.23K ﹤0.01% 4646

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tower Research Capital (TRC)'s WGS Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its GeneDx Holdings (WGS) stake by 172% in Q1 2026, buying an estimated $60.7K and bringing the position to 1,053 shares worth $67.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2493.

Tower Research Capital (TRC) first reported a position in WGS in Q4 2020 and has held it in 19 quarters since. The position peaked at $351K in Q3 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Tower Research Capital (TRC) held 1,053 shares of GeneDx Holdings worth $67.6K as of Q1 2026.
  • Tower Research Capital (TRC) bought 666 GeneDx Holdings shares in Q1 2026, an estimated $60.7K.
  • GeneDx Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2493 holding.
  • Tower Research Capital (TRC) first reported a position in GeneDx Holdings in Q4 2020 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s GeneDx Holdings position peaked at $351K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.